Major Trial Finds Post-Heart Attack Beta-Blockers Unnecessary for Most, With Added Risk for Women

The Reboot study enrolled 8,505 patients in Spain and Italy in the modern reperfusion era to reassess long-term therapy after uncomplicated infarction.